A team at Medicinal Genomics have successfully sequenced the cannabis genome at 640kb N50, representing a 28% improvement on the Human Genome Project standard.
Across four distinct strains it was observed that the flower samples taken from the upper third of the plant had a higher THC content than those at the base of the plant, and in two of the strains tested the difference was equivalent to the upper flowers being around twice as potent as the lower flowers.
Whether it is introduced at the cultivator, processor or manufacturer level, ETCH biotrace links a unique molecular tag to the cannabis plant that will survive conversion or extraction.
The researchers behind the work were keen to point out that there is still little evidence to prove that the pathogens present in cannabis samples have directly led to infections in immunocompromised patients.
Examining a broad array of cannabinoids and terpenes reveals the inherent failings of commonly used cannabis classification systems.